HSBC HOLDINGS PLC

Position in ABSI — Absci Corp

CIK 873630 LONDON, X0

Position in ABSI

as of Mar 31, 2026 · filed Apr 30, 2026 Compact

Position Value

$193,524

-$37,632 QoQ

Shares Held

64,508

-2.6% QoQ

Ownership

0.041%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

14 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

HSBC HOLDINGS PLC holds $964,220,373 across 121 Biotechnology names. ABSI ranks #93 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	655,443	$292,681,510
2	REGN	Regeneron Pharmaceuticals, Inc.	323,338	$249,823,869
3	RPRX	Royalty Pharma plc	1,544,018	$74,066,541
4	INCY	Incyte Corp	582,368	$54,812,474
5	ALNY	Alnylam Pharmaceuticals, Inc.	89,619	$29,652,235
6	MRNA	Moderna, Inc.	490,088	$24,896,468
7	INSM	INSMED Inc	116,456	$19,042,883
8	PTCT	Ptc Therapeutics, Inc.	227,059	$15,469,528

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$193,524	64,508	-2.6%	Shares	Defined	2026-04-30
2025-12-31	$231,156	66,234	-3.8%	Shares	Defined	2026-03-20
2025-09-30	$209,325	68,857	+243.5%	Shares	Defined	2025-11-13
2025-06-30	$51,518	20,046	-19.2%	Shares	Defined	2025-08-13
2025-03-31	$62,268	24,808	-18.4%	Shares	Defined	2025-05-14
2024-12-31	$79,613	30,387	-1.3%	Shares	Defined	2025-02-14
2024-09-30	$117,560	30,775	-82.0%	Shares	Defined	2024-11-14
2024-06-30	$526,886	171,067	-58.0%	Shares	Defined	2024-08-12
2024-03-31	$2,315,048	407,579	0.0%	Shares	Defined	2024-05-15
2023-12-31	$1,711,831	407,579	+153.8%	Shares	Defined	2024-02-12
2023-09-30	$211,939	160,560	0.0%	Shares	Defined	2023-11-13
2023-06-30	$244,051	160,560	+11.7%	Shares	Defined	2023-08-11
2023-03-31	$251,660	143,806	+485.1%	Shares	Defined	2023-05-15
2022-12-31	$51,615	24,579	—	Shares	Defined	2023-02-14
No filing history on record for this holder in this stock.